Immunogenicity and Efficacy Evaluation of Vero Cell-Adapted Infectious Bursal Disease Virus LC-75 Vaccine Strain.

IF 1.7 Q2 VETERINARY SCIENCES
Veterinary medicine (Auckland, N.Z.) Pub Date : 2021-10-01 eCollection Date: 2021-01-01 DOI:10.2147/VMRR.S326479
Wakjira Kebede, Molalegne Bitew, Fufa Dawo Bari, Bedaso Mammo Edao, Hawa Mohammed, Martha Yami, Belayneh Getachew, Takele Abayneh, Esayas Gelaye
{"title":"Immunogenicity and Efficacy Evaluation of Vero Cell-Adapted Infectious Bursal Disease Virus LC-75 Vaccine Strain.","authors":"Wakjira Kebede,&nbsp;Molalegne Bitew,&nbsp;Fufa Dawo Bari,&nbsp;Bedaso Mammo Edao,&nbsp;Hawa Mohammed,&nbsp;Martha Yami,&nbsp;Belayneh Getachew,&nbsp;Takele Abayneh,&nbsp;Esayas Gelaye","doi":"10.2147/VMRR.S326479","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Infectious bursal disease virus (IBDV) is an avian viral pathogen that causes infectious bursal disease (IBD) of chickens. The disease has been endemic in Ethiopia since 2002, and vaccination has been practiced as the major means of disease prevention and control. An IBD vaccine is produced in Ethiopia using primary chicken embryo fibroblast (CEF) cell, which is time-consuming, laborious, and uneconomical. The present study was carried out to develop cell-based IBDV LC-75 vaccine using Vero cells and to evaluate the safety, immunogenicity and protection level.</p><p><strong>Methods: </strong>Identity of the vaccine seed was confirmed with gene-specific primers using reverse transcription polymerase chain reaction (RT-PCR). Confluent monolayer of Vero cells was infected with vaccine virus and serial passage continued till passage 10. A characteristic virus-induced cytopathic effect (CPE) was observed starting from passage 2 on the third day post-infection. The infectious titer of adapted virus showed a linear increment along the passage level. The virus-induced specific antibody was determined using indirect ELISA after vaccination of chicks through ocular route.</p><p><strong>Results: </strong>The antibody titer measured from Vero cells vaccinated chicks revealed similar level with the currently available CEF cell-based vaccine, hence no significant difference. Chicks vaccinated with Vero cell adapted virus showed complete protection against very virulent IBDV, while unvaccinated group had 60% morbidity and 25% mortality.</p><p><strong>Conclusion: </strong>It is concluded that the IBDV vaccine strain well adapted on Vero cells and found to be immunogenic induces antibody development and successfully protects chicks against challenge with the circulating field IBDV isolate. Hence, it is recommended to produce IBD vaccine using Vero cell culture at the industrial scale to conquer the limitations caused by using CEF cells and thus to vaccinate chicks population to protect against the circulating IBDV infection.</p>","PeriodicalId":75300,"journal":{"name":"Veterinary medicine (Auckland, N.Z.)","volume":"12 ","pages":"261-270"},"PeriodicalIF":1.7000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7d/e6/vmrr-12-261.PMC8493110.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary medicine (Auckland, N.Z.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/VMRR.S326479","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 4

Abstract

Introduction: Infectious bursal disease virus (IBDV) is an avian viral pathogen that causes infectious bursal disease (IBD) of chickens. The disease has been endemic in Ethiopia since 2002, and vaccination has been practiced as the major means of disease prevention and control. An IBD vaccine is produced in Ethiopia using primary chicken embryo fibroblast (CEF) cell, which is time-consuming, laborious, and uneconomical. The present study was carried out to develop cell-based IBDV LC-75 vaccine using Vero cells and to evaluate the safety, immunogenicity and protection level.

Methods: Identity of the vaccine seed was confirmed with gene-specific primers using reverse transcription polymerase chain reaction (RT-PCR). Confluent monolayer of Vero cells was infected with vaccine virus and serial passage continued till passage 10. A characteristic virus-induced cytopathic effect (CPE) was observed starting from passage 2 on the third day post-infection. The infectious titer of adapted virus showed a linear increment along the passage level. The virus-induced specific antibody was determined using indirect ELISA after vaccination of chicks through ocular route.

Results: The antibody titer measured from Vero cells vaccinated chicks revealed similar level with the currently available CEF cell-based vaccine, hence no significant difference. Chicks vaccinated with Vero cell adapted virus showed complete protection against very virulent IBDV, while unvaccinated group had 60% morbidity and 25% mortality.

Conclusion: It is concluded that the IBDV vaccine strain well adapted on Vero cells and found to be immunogenic induces antibody development and successfully protects chicks against challenge with the circulating field IBDV isolate. Hence, it is recommended to produce IBD vaccine using Vero cell culture at the industrial scale to conquer the limitations caused by using CEF cells and thus to vaccinate chicks population to protect against the circulating IBDV infection.

Abstract Image

Abstract Image

Abstract Image

Vero细胞适应性传染性法氏囊病病毒LC-75疫苗株的免疫原性和疗效评价。
传染性法氏囊病病毒(IBDV)是一种引起鸡传染性法氏囊病(IBD)的禽病毒病原体。自2002年以来,该病在埃塞俄比亚流行,接种疫苗是预防和控制该病的主要手段。埃塞俄比亚使用原代鸡胚成纤维细胞(CEF)生产了一种IBD疫苗,这种方法耗时、费力且不经济。本研究利用Vero细胞开发IBDV LC-75细胞基疫苗,并对其安全性、免疫原性和保护水平进行评价。方法:采用逆转录聚合酶链式反应(RT-PCR),用基因特异性引物对疫苗种子进行鉴定。用疫苗病毒感染Vero细胞的融合单层,连续传代至第10代。从传代2开始,在感染后第3天观察到特征性的病毒诱导细胞病变效应(CPE)。适应病毒的感染滴度沿传代水平呈线性增长。经眼路接种雏鸡后,采用间接ELISA法测定病毒诱导的特异性抗体。结果:Vero细胞接种雏鸡的抗体滴度与目前可用的CEF细胞疫苗的抗体滴度相近,无显著差异。接种Vero细胞适应病毒的雏鸡对非常强毒的IBDV具有完全的保护作用,而未接种组的发病率为60%,死亡率为25%。结论:IBDV疫苗株在Vero细胞上具有良好的适应性和免疫原性,诱导了抗体的产生,并成功地保护了雏鸡免受IBDV循环场分离物的攻击。因此,建议在工业规模上利用Vero细胞培养生产IBD疫苗,以克服使用CEF细胞的局限性,从而为鸡群接种疫苗,以防止循环IBDV感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信